WhatsApp

A Diabetes Drug May Help Women With Ovarian Cancer Live Longer

You are here >> Home > Latest Updates > Ovarian Cancer > A Diabetes…

A Diabetes Drug May Help Women With Ovarian Cancer Live Longer

Doctors are learning that some medications used for other health problems might also help cancer patients. A new study found that a type of medicine used to treat diabetesโ€”called GLP-1 receptor agonists (GLP-1RA)โ€”may help women with ovarian cancer live longer.

Researchers looked at health records of over 2,000 women with ovarian cancer. Half had taken GLP-1RA drugs, and half had not. These women were matched so their age, cancer stage, and other health issues were similar.

The results were encouraging. Only about 8% of women who used GLP-1RA had died, compared to nearly 20% of those who didnโ€™t. This suggests a strong survival benefit.

The benefit remained even in women who were also getting chemotherapy or other cancer treatments. It didnโ€™t seem to help women with serious heart or kidney problems, but it worked well in most other groups.

GLP-1RA drugs are already widely used and have a good safety record. They may become a useful extra tool for women with ovarian cancer, especially those who also have diabetes or weight issues.

More research is needed, but this is a hopeful step toward better outcomes.

Rate this post

Exclusive Health Tips and Updates

dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.